Intervention and Evaluation of Mobile Health Technologies in Management of Patients Undergoing Chronic Dialysis: Scoping Review

Abstract

Background Studies have shown the effectiveness and user acceptance of mobile health (mHealth) technologies in managing patients with chronic kidney disease (CKD). However, incorporating mHealth technology into the standard care of patients with CKD still faces many challenges. To our knowledge, there are no reviews on mHealth interventions and their assessments concerning the management of patients undergoing dialysis. Objective This study provided a scoping review on existing apps and interventions of mHealth technologies in adult patients undergoing chronic dialysis and identified the gaps in patient outcome assessment of mHealth technologies in the literature. Methods We systematically searched PubMed (MEDLINE), Scopus, and the Cumulative Index to Nursing and Allied Health Literature databases, as well as gray literature sources. Two keywords, “mHealth” and “dialysis,” were combined to address the main concepts of the objectives. Inclusion criteria were as follows: (1) mHealth interventions, which are on a smartphone, tablet, or web-based portals that are accessible through mobile devices; and (2) adult patients (age ≥18 years) on chronic dialysis. Only English papers published from January 2008 to October 2018 were included. Studies with mHealth apps for other chronic conditions, based on e-consultation or videoconferencing, non-English publications, and review papers were excluded. Results Of the 1054 papers identified, 22 met the inclusion and exclusion criteria. Most studies (n=20) were randomized controlled trials and cohort studies. These studies were carried out in 7 countries. The main purposes of these mHealth interventions were as follows: nutrition or dietary self-monitoring (n=7), remote biometric monitoring (n=7), web-based portal (n=4), self-monitoring of in-session dialysis-specific information (n=3), and self-monitoring of lifestyle or behavioral change (n=1). The outcomes of the 22 included studies were organized into five categories: (1) patient satisfaction and acceptance, (2) clinical effectiveness, (3) economic assessment, (4) health-related quality of life, and (5) impact on lifestyle or behavioral change. The mHealth interventions showed neutral to positive results in chronic dialysis patient management, reporting no to significant improvement of dialysis-specific measurements and some components of the overall quality of life assessment. Evaluation of these mHealth interventions consistently demonstrated evidence in patients’ satisfaction, high level of user acceptance, and reduced use of health resources and cost savings to health care services. However, there is a lack of studies evaluating safety, organizational, sociocultural, ethical, and legal aspects of mHealth technologies. Furthermore, a comprehensive cost-effectiveness and cost-benefit analysis of adopting mHealth technologies was not found in the literature. Conclusions The gaps identified in this study will inform the creation of health policies and organizational support for mHealth implementation in patients undergoing dialysis. The findings of this review will inform the development of a comprehensive service model that utilizes mHealth technologies for home monitoring and self-management of patients undergoing chronic dialysis.

Using patient-reported outcome measures during the management of patients with end-stage kidney disease requiring treatment with haemodialysis (PROM-HD): a qualitative study

“… 26 27 However, the overall impact and benefit of PRO use in dialysis care is yet to be established. 28 In comparison, PRO research in oncology has shown defined benefits ranging from improved QoL and reduction in hospitalisations to overall survival 29 and even cost-effectiveness. 30 …”

Mobile Health, Disease Knowledge, and Self-Care Behavior in Chronic Kidney Disease: A Prospective Cohort Study

“…CKD management is challenging, and includes prevention, early diagnosis, and the development of a thorough disease-management program [ 3 , 4 ]. Mobile health (mHealth) is an emerging strategy of care for patients with chronic diseases, such as diabetes mellitus (DM), hypertension, heart disease, stroke and asthma, that is accessible through mobile devices such as smartphones, tablets, or web-based portals [ 5 ]. mHealth has been shown to improve communication between healthcare professionals and patients and to facilitate monitoring bio-information at home and health behavior management, and to further promote the early detection of a worsening health status [ 6 ].…”

The Potential of mHealth as a Game Changer for the Management of Sickle Cell Disease in India

“…There are more than 325,000 mHealth apps available for Android and Apple smartphones [6]. Various mHealth apps have been clinically tested for their effect on compliance for many chronic diseases worldwide [7][8][9][10][11] and there are mounting indications that support the feasibility and applicability of mHealth interventions for better compliance in managing chronic diseases in pediatric patients as well. During the ongoing COVID-19 pandemic, mHealth has emerged as a silver bullet, not only for teleconsultations and telemonitoring of patients with chronic diseases, but also for increasing health care delivery in remote areas [12][13][14].…”